5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Indegene Ltd.

•
indegene.comBSE: 544172NSE: INDGN
Market Cap₹ 13,929 Cr.
Current Price
High / Low₹ 616 / 414
Stock P/E61.4
Book Value₹ 87
Price to Book5.14
Dividend Yield0.39 %
ROCE14.6 %
ROE10.9 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Latest quarter profit grew 32.8% YoY, showing strong momentum
  • Company has delivered good sales growth of 19.0% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.23x)

CONS

  • Recent results are weak - TTM profit is down 13.5% versus prior year
  • A large part of profit comes from other income (28.4% of PBT)
  • Stock is trading at 5.1x its book value
  • Expensive relative to growth - PEG of 3.5
  • Rich enterprise valuation - EV/EBITDA of 31.6x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareBusiness ServicesBusiness Support
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.PFOCUS310.60209.2824188.720.00-457.78-514.4312668.151196.882.7423.76
2.SAGILITY45.1521.2821136.200.33216.8145.941963.4827.5913.8222.32
3.HORIZONIND55.65244.0316043.350.00-116.27—2005.46—3.3280.26
4.SYNGENE382.6569.8915446.400.33-9.00-110.38736.00-15.849.4812.34
5.INDGN578.0534.7413929.080.39116.20-0.171063.1039.7318.9216.39
6.IGIL314.2022.2713578.461.59165.7430.98370.7823.2277.0060.35
7.NESCO1102.7518.657769.970.6399.963.97211.809.5519.2348.33
8.LEAPIND144.55102.156367.950.00247.33—2034.13—9.3251.19
9.SPARC196.104.026363.870.00-20.7859.9439.92314.11163.94-85.17
10.SMARTWORKS530.60217.746069.060.0013.15413.27546.2544.0561.1263.33
11.JUSTDIAL665.1015.595656.610.00115.7438.44270.2716.2312.8826.17
12.LATENTVIEW252.5026.765228.850.0047.10-6.84286.8821.5516.6919.76
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
252260260272259282287267256307290368341
215217223226219235235227219236252265295
Operating Profit384337464046524037713810346
OPM %14.89%16.66%14.23%17.03%15.27%16.47%18.10%14.85%14.36%23.02%13.00%28.00%13.53%
126122314222235321823634
Interest2222222222233
Depreciation9868766779101111
Profit before Tax39394160456166666078499580
Tax %24.30%25.63%27.45%19.04%27.72%26.56%24.51%18.37%24.58%22.71%28.98%24.26%25.12%
Net Profit30293049334550544560357260
1.341.321.342.201.411.882.092.261.882.501.453.002.49

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1921982823345118371,0061,0461,0941,2211,306
1602022302493616688288789139741,048
Operating Profit33-45286150169178168181246258
OPM %17.01%-1.87%18.48%25.68%29.35%20.16%17.66%16.07%16.51%20.19%19.72%
3712-2928283750908080
Interest111343676910
Depreciation4441318243231263640
Profit before Tax31-15941156170177181238281302
Tax %4.04%-480.92%14.03%33.99%17.20%21.90%26.27%23.64%23.98%24.70%24.86%
Net Profit30-65127130133130138181212227
EPS149.28-79.64271.82200.316.196.015.866.217.578.81—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%26.42%25.54%—

COMPOUNDED SALES GROWTH

10 Years:
23%
5 Years:
19%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
22%
5 Years:
10%
3 Years:
18%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
2%

RETURN ON EQUITY

10 Years:
30%
5 Years:
18%
3 Years:
13%
Last Year:
11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jul 31

₹ 1.12

Rs.2.2500 per share(112.5%)Final Dividend

2025

Jun 13

₹ 1

Rs.2.0000 per share(100%)Final Dividend

2026

Jul 15

₹ 1.12

Rs.2.2500 per share(112.5%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
00000044444848
109104155-82496447338781,8041,986
51028353123338251462
Trade Payables25212534432624573533
1031061123550137184200228329
Total Liabilities2422413194143548401,0241,2052,1282,458
988314172785653113
Capital Work in Progress00000000412
9072134251832034006249751,318
0000000378418288
Cash & Bank45153618395416164130
13915616295212525491132515598
Total Assets2422413194143548401,0241,2052,1282,458

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
519761047974124176129346
Cash from Investing-35-8-70-51-33-267-48-188-825-272
Cash from Financing-5315-18-37245-17-16717-63
10820-171617-272211

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters0.000.000.000.000.000.000.000.000.00
3.794.825.035.2410.0411.3011.4810.279.92
3.843.173.984.967.206.958.068.298.74
Government0.000.000.000.000.000.000.000.000.00
92.3792.0191.0089.8082.7581.7480.4581.4481.35

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Amalgamation/Merger

2026-09-10 - Indegene Limited has informed the Exchange about Amalgamation/Merger of Indirect Wholly Owned Subsidiaries of the Company in Germany

2026-09-08
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Indegene Limited has informed the Exchange about Schedule of meet

2026-08-31
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-31 - Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-19
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Indegene Limited has informed the Exchange about Schedule of meet

2026-08-19
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-19 - Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-17
General Updates

2026-08-17 - Indegene Limited has informed the Exchange about the Transcript of the 28th Annual General Meeting held on August 13, 2026

2026-08-17
Change in Director(s)

2026-08-17 - Indegene Limited has informed the Exchange regarding Change in Director(s) of the company.

2026-08-17
Shareholders meeting

2026-08-17 - Indegene Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 13, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-14
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Indegene Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for INDGN

Loading news…

🤖

AI Stock Analyst

Indegene Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login